Dr. Jill Kolesar is a University Research Professor in the College of Pharmacy at the University of Kentucky, the Dr. Michael Karpf Endowed Chair in Precision Medicine and holds administrative positions as the Co-Leader of the Translational Oncology Program at the Markey Cancer Center and a joint appointment in the Division of Gynecologic Oncology in the College of Medicine. Dr. Kolesar received her PharmD degree at the University of Texas Health Science Center in San Antonio, where she also completed a specialty practice residency in oncology/hematology and a fellowship in molecular oncology pharmacotherapy. She received an MS in epidemiology with an emphasis in genetic epidemiology from the University of Wisconsin-Madison, College of Medicine and Public Health in 2016.
She has extensive experience in both developing and leading clinical trials and Molecular Tumor Boards. Dr. Kolesar has authored more than 350 abstracts, research articles and book chapters, and as a principal investigator she has received more than $15M in research funding from the NCI, American Cancer Society and other sources.
Chief Executive Officer, Pontchartrain Cancer Center
Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana. She is a board member of the Community Oncology Alliance and co-chairs the Biosimilars committee and serves on their Government Affairs committee. Kathy chairs the NCODA (National Community Oncology Dispensing Association) Oncology Institute. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health. Kathy is a member of the Association of Community Cancer Centers and serves on their Oral Oncolytics Advisory committee. She is a member of the national Medical Group Management Association (MGMA) and serves on their government affairs group. She is also the past president for the Louisiana MGMA and chairs their government affairs committee. Kathy also serves on the editorial boards for the Center for Biosimilars and the Journal of Evidence-Based Managed Care.